| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |